SATB2 induces stem-like properties and promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
暂无分享,去创建一个
[1] Yuan Luo,et al. SATB2 suppresses non-small cell lung cancer invasiveness by G9a , 2018, Clinical and Experimental Medicine.
[2] Su-jin Yang,et al. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. , 2016, Gene.
[3] Y. Li,et al. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells , 2016, World journal of gastroenterology.
[4] H. Akça,et al. Downregulation of SATB2 is critical for induction of epithelial-to-mesenchymal transition and invasion of NSCLC cells. , 2016, Lung cancer.
[5] S. Shankar,et al. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker , 2016, Oncotarget.
[6] Xianwei Mo,et al. SATB2 suppresses gastric cancer cell proliferation and migration , 2016, Tumor Biology.
[7] Xin Yu,et al. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2 , 2015, Oncotarget.
[8] G. Gores,et al. Hepatocellular carcinoma: clinical frontiers and perspectives , 2014, Gut.
[9] Wai Leong Tam,et al. The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.
[10] M. Zeng,et al. Decreased Expression of SATB2: A Novel Independent Prognostic Marker of Worse Outcome in Laryngeal Carcinoma Patients , 2012, PloS one.
[11] R. Weinberg,et al. Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells? , 2011, International journal of cancer.
[12] Rune Thomsen,et al. Analysis of Qpcr Data by Converting Exponentially Related CT Values into Linearly Related X0 Values , 2010, J. Bioinform. Comput. Biol..
[13] M. Petz,et al. Epithelial-mesenchymal transition in hepatocellular carcinoma. , 2009, Future oncology.
[14] Jin-Lin Hou,et al. Hepatocellular carcinoma in the Asia pacific region , 2009, Journal of gastroenterology and hepatology.
[15] S. Byers,et al. Liver stem cells and hepatocellular carcinoma , 2009, Hepatology.
[16] M. Konstadoulakis,et al. Strategies for the management of hepatocellular carcinoma , 2007, Nature Clinical Practice Oncology.
[17] C. Paweletz,et al. Isolation and Characterization of SATB2, a Novel AT-rich DNA Binding Protein Expressed in Development- and Cell-Specific Manner in the Rat Brain , 2006, Neurochemical Research.
[18] D. Tarin,et al. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.
[19] Q. Ye,et al. A decade’s studies on metastasis of hepatocellular carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.
[20] D. Bonthron,et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. , 2003, Human molecular genetics.
[21] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.